Biohaven Pharma (BHVN) Misses Q1 EPS by 4c
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.88), $0.04 worse than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.88), $0.04 worse than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.